Mindmed cmo to chair digital biomarkers summit

New york, oct. 25, 2021 /prnewswire/ -- mind medicine (mindmed) inc. (nasdaq: mnmd), (neo: mmed), (de: mmq) (the "company"), a leading biotech company developing psychedelic-inspired therapies, is pleased to announce that chief medical officer daniel r karlin, md ma, will chair the digital biomarkers & digital measurements summit , held virtually on october 26 - 27, 2021. "digital biomarkers and digital measurements are an area of great interest in pharmaceutical development and the delivery of healthcare.
MNMD Ratings Summary
MNMD Quant Ranking